The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 38,190,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
ACELYRIN INC | COM | 00445A100 | 8,790,256 | 864,332 | SH | SOLE | 864,332 | 0 | 0 | |||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 7,129,165 | 1,040,754 | SH | SOLE | 1,040,754 | 0 | 0 | |||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 9,859,950 | 6,573,300 | SH | SOLE | 6,573,300 | 0 | 0 | |||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 3,614,167 | 295,034 | SH | SOLE | 295,034 | 0 | 0 | |||
AFFIMED N V | COM | N01045108 | 682,714 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | |||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 23,805,000 | 2,070,000 | SH | SOLE | 2,070,000 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 180,907,737 | 8,493,321 | SH | SOLE | 8,493,321 | 0 | 0 | |||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 14,088,505 | 5,658,034 | SH | SOLE | 5,658,034 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 30,032,911 | 1,973,253 | SH | SOLE | 1,973,253 | 0 | 0 | |||
CELCUITY INC | COM | 15102K100 | 19,243,228 | 2,105,386 | SH | SOLE | 2,105,386 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 45,670,628 | 4,684,167 | SH | SOLE | 4,684,167 | 0 | 0 | |||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 12,681,741 | 927,706 | SH | SOLE | 927,706 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 19,478,260 | 2,173,913 | SH | SOLE | 2,173,913 | 0 | 0 | |||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 40,363,961 | 2,954,902 | SH | SOLE | 2,954,902 | 0 | 0 | |||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 27,578,456 | 2,744,125 | SH | SOLE | 2,744,125 | 0 | 0 | |||
HILLEVAX INC | COM | 43157M102 | 27,401,860 | 2,037,313 | SH | SOLE | 2,037,313 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 28,087,503 | 2,916,667 | SH | SOLE | 2,916,667 | 0 | 0 | |||
LYRA THERAPEUTICS INC | COM | 55234L105 | 3,613,505 | 924,170 | SH | SOLE | 924,170 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 14,386,560 | 11,328,000 | SH | SOLE | 11,328,000 | 0 | 0 | |||
MERUS N V | COM | N5749R100 | 40,704,126 | 1,726,214 | SH | SOLE | 1,726,214 | 0 | 0 | |||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 6,847,317 | 2,208,812 | SH | SOLE | 2,208,812 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 951,469 | 77,042 | SH | SOLE | 77,042 | 0 | 0 | |||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 12,964,279 | 2,142,856 | SH | SOLE | 2,142,856 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 32,630,516 | 1,563,513 | SH | SOLE | 1,563,513 | 0 | 0 | |||
PLIANT THERAPEUTICS INC | COM | 729139105 | 5,010,376 | 288,949 | SH | SOLE | 288,949 | 0 | 0 | |||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 9,070,541 | 5,304,410 | SH | SOLE | 5,304,410 | 0 | 0 | |||
RALLYBIO CORP | COM | 75120L100 | 904,953 | 268,532 | SH | SOLE | 268,532 | 0 | 0 | |||
RAYZEBIO INC | COM | 75525N107 | 89,174,003 | 4,016,847 | SH | SOLE | 4,016,847 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 24,988,250 | 1,090,000 | SH | SOLE | 1,090,000 | 0 | 0 | |||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 4,532,000 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 27,158,790 | 7,184,865 | SH | SOLE | 7,184,865 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 45,644,443 | 14,444,444 | SH | SOLE | 14,444,444 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 15,554,133 | 3,092,273 | SH | SOLE | 3,092,273 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 23,455,672 | 2,623,677 | SH | SOLE | 2,623,677 | 0 | 0 | |||
TREVI THERAPEUTICS INC | COM | 89532M101 | 7,460,825 | 3,422,397 | SH | SOLE | 3,422,397 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 47,287,421 | 3,082,622 | SH | SOLE | 3,082,622 | 0 | 0 |